Literature DB >> 24947101

ICON 2013: practical consensus recommendations for hormone receptor-positive Her2-negative advanced or metastatic breastcancer.

P M Parikh1, S Gupta, S Dawood, H Rugo, G S Bhattacharyya, A Agarwal, R Chacko, T P Sahoo, G Babu, S Agarwal, A Munshi, C Goswami, B K Smruti, S Bondarde, C Desai, S Rajappa, N Somani, M Singh, R Nimmagadda, K Pavitran, A Mehta, V Parmar, S Desai, R Nair, D Doval.   

Abstract

The management of hormone receptor-positive Her2-negative breast cancer patients with advanced or metastatic disease is a common problem in India and other countries in this region. This expert group used data from published literature, practical experience, and opinion of a large group of academic oncologists, to arrive at practical consensus recommendations for use by the community oncologists.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24947101     DOI: 10.4103/0019-509X.134650

Source DB:  PubMed          Journal:  Indian J Cancer        ISSN: 0019-509X            Impact factor:   1.224


  3 in total

1.  Efficacy and safety of short course adjuvant trastuzumab combination chemotherapy in breast cancer.

Authors:  Sachin S Hingmire; Mahesh B Sambhus; Dhananjay S Kelkar; Sujit Joshi; Purvish M Parikh; R Bharath
Journal:  South Asian J Cancer       Date:  2017 Apr-Jun

2.  Editorial.

Authors:  Purvish M Parikh; Shyam Aggarwal; Sachin Hingmire
Journal:  South Asian J Cancer       Date:  2018 Apr-Jun

Review 3.  Shared decision making in breast cancer treatment guidelines: Development of a quality assessment tool and a systematic review.

Authors:  Marta Maes-Carballo; Isabel Muñoz-Núñez; Manuel Martín-Díaz; Luciano Mignini; Aurora Bueno-Cavanillas; Khalid Saeed Khan
Journal:  Health Expect       Date:  2020-08-03       Impact factor: 3.377

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.